Spectrum Pharma Closes RIT Oncology Acquisition

Spectrum Pharmaceuticals, Inc. said it closed the acquisition of RIT Oncology LLC by making the final payment of the $18 million deal to its former partner Cell Therapeutics, Inc.
RTTNews